Category Archives: Uncategorized

Adaptive pathways for medicine evaluation and unmet medical need: the access v. evidence dilemma

The European Medicines Agency hosted a stakeholder workshop on 8th December 2016 on adaptive pathways at its Canary Wharf London headquarters: a hot topic with around 150 delegates from healthcare, patient and consumer organisations, academia, industry and regulatory bodies. The

Adaptive pathways for medicine evaluation and unmet medical need: the access v. evidence dilemma

The European Medicines Agency hosted a stakeholder workshop on 8th December 2016 on adaptive pathways at its Canary Wharf London headquarters: a hot topic with around 150 delegates from healthcare, patient and consumer organisations, academia, industry and regulatory bodies. The

Preventing stroke in general practice: major room for improvement

One in four patients in primary care is not being adequately treated with anti-coagulation to reduce the high stroke risk associated with a common form of the heart rhythm disorder atrial fibrillation. These are the findings of a report by

Preventing stroke in general practice: major room for improvement

One in four patients in primary care is not being adequately treated with anti-coagulation to reduce the high stroke risk associated with a common form of the heart rhythm disorder atrial fibrillation. These are the findings of a report by